Comparison of gene expression profiles of lymphoma cell lines from transformed follicular lymphoma, Burkitt's lymphoma and de novo diffuse large B-cell lymphoma

被引:23
|
作者
Maesako, Y [1 ]
Uchiyama, T [1 ]
Ohno, H [1 ]
机构
[1] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Sakyo Ku, Kyoto 6068507, Japan
关键词
D O I
10.1111/j.1349-7006.2003.tb01518.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To determine the specific gene expression in B-cell lymphoma subtypes, we compared expression profiles of cell lines from transformed follicular lymphoma (tFL), Epstein-Barr virus-negative (EBV(-)) Burkitt's lymphoma (BL) and EBV(+)BL. Complementary DNAs were synthesized from these cell lines and hybridized with the Atlas Human 1.2 Array membrane. Hierarchical clustering analysis based upon the levels of 43 genes highlighted characteristic expression patterns of the 3 lymphoma subtypes. Genes expressed at higher levels in tFL than EBV(-)BL and EBV(+)BL included calcium/calmodulin-dependent protein kinase I (CAMK1) and mitogen-activated protein kinase 10 (MAPK10). EBV(-)BL was characterized by high-level expression of amyloid beta precursor protein (APP), heat shock 27 kD protein 1 (HSPB1) and mothers against decapentaplegic homolog 1 (MADH1). Gardner-Rasheed feline sarcoma viral oncogene homolog (FGR) was the most significant gene to delineate EBV(+)BL. A subtype prediction algorithm using 34 genes correctly classified 22 (92%) of 24 lymphomas into FL/tFL, EBV(-)BL or EBV(+)BL. By comparison with normal reference B-cell materials, the expression patterns of the selected genes were characteristic of lymphomas. We extended the clustering analysis to cell lines from de novo diffuse large B-cell lymphoma (DLBCL). The DLBCL cell lines were either separated from the former 3 lymphoma subtypes or segregated with EBV(+)BL, possibly reflecting variable genetic abnormalities. The associations of CAMK1 with tFL, APP and MADH1 with EBV(-)BL, FGR with EBV(+)BL, and BCL2 with tFL and DLBCL were confirmed by real-time quantitative reverse transcriptase-mediated polymerase chain reaction assays. This study has provided new molecular markers, expressions of which are closely associated with B-cell lymphoma subtypes.
引用
收藏
页码:774 / 781
页数:8
相关论文
共 50 条
  • [21] ABF-1 is frequently silenced by promoter methylation in follicular lymphoma, diffuse large B-cell lymphoma and Burkitt's lymphoma
    A Ushmorov
    F Leithäuser
    O Ritz
    T F E Barth
    P Möller
    T Wirth
    Leukemia, 2008, 22 : 1942 - 1944
  • [22] Outcomes of Hematopoietic Cell Transplantation for Diffuse Large B Cell Lymphoma Transformed from Follicular Lymphoma
    Wirk, Baldeep
    Fenske, Timothy S.
    Hamadani, Mehdi
    Zhang, Mei-Jie
    Hu, Zhen-Huan
    Akpek, Goerguen
    Aljurf, Mahmoud D.
    Armand, Philippe
    Ayala, Ernesto
    Bachanova, Veronika
    Bolwell, Brian
    Cairo, Mitchell S.
    Cashen, Amanda
    Chen, Yi-Bin
    Costa, Luciano J.
    Farhan, Shatha
    Freytes, Cesar O.
    Gajewski, James L.
    Gibson, John
    Hale, Gregory A.
    Holmberg, Leona A.
    Hsu, Jack W.
    Inwards, David J.
    Kamble, Rummurti T.
    Maharaj, Dipnarine
    Maziarz, Richard T.
    Munker, Reinhold
    Nath, Rajneesh
    Reddy, Nishitha M.
    Reeder, Craig B.
    Rizzieri, David A.
    Sauter, Craig S.
    Savani, Bipin N.
    Schouten, Harry C.
    Sureda, Anna
    Vose, Julie M.
    Waller, Edmund K.
    Wiernik, Peter H.
    Gale, Robert Peter
    Burns, Linda J.
    Saber, Wael
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (07) : 951 - 959
  • [23] Diagnosis and treatment in patients with B-cell lymphoma unclassified that is intermediate between diffuse large B-cell lymphoma and Burkitt's lymphoma
    Baryakh, E. A.
    Misyurina, A. E.
    Kovrigina, A. M.
    Obukhova, T. N.
    Gemdzhyan, E. G.
    Vorobyev, V. I.
    Mangasarova, Ya. K.
    Polyakov, Yu. Yu.
    Magomedova, A. U.
    Klyasova, G. A.
    Misyurin, V. A.
    Yatsyk, G. A.
    Shevelev, A. A.
    Kostina, I. E.
    Vorobyev, A. I.
    Kravchenko, S. K.
    TERAPEVTICHESKII ARKHIV, 2015, 87 (08) : 77 - 85
  • [24] Diffuse large B cell lymphoma versus Burkitt lymphoma
    Kluin, P.
    VIRCHOWS ARCHIV, 2010, 457 (02) : 108 - 108
  • [25] Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach
    Bellan, Cristiana
    Stefano, Lazzi
    Giulia, De Falco
    Rogena, Emily A.
    Lorenzo, Leoncini
    HEMATOLOGICAL ONCOLOGY, 2010, 28 (02) : 53 - 56
  • [26] Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach
    Bellan, Cristiana
    Stefano, Lazzi
    Giulia, De Falco
    Rogena, Emily A.
    Lorenzo, Leoncini
    HEMATOLOGICAL ONCOLOGY, 2009, 27 (04) : 182 - 185
  • [27] Clinicopathological prognostic indicators in 107 patients with diffuse large B-cell lymphoma transformed from follicular lymphoma
    Maeshima, Akiko M.
    Taniguchi, Hirokazu
    Fukuhara, Suguru
    Maruyama, Dai
    Kim, Sung-Won
    Watanabe, Takashi
    Kobayashi, Yukio
    Tobinai, Kensei
    Tsuda, Hitoshi
    CANCER SCIENCE, 2013, 104 (07) : 952 - 957
  • [28] A composite lymphoma combining a Hodgkin lymphoma and a marginal zone lymphoma transformed into a diffuse large B-cell lymphoma
    Auditeau, Claire
    Lambotte, Olivier
    Feriel, Joffrey
    Lazure, Thierry
    Turhan, Ali
    Aumont, Cedric
    CLINICAL CASE REPORTS, 2018, 6 (12): : 2341 - 2346
  • [29] Diffuse Large B-Cell Lymphomas and Burkitt Lymphoma
    de Leval, Laurence
    Hasserjian, Robert Paul
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2009, 23 (04) : 791 - +
  • [30] Diffuse Large B Cell Lymphoma Coexistent with Follicular Cell Lymphoma
    Zhang, Ling
    Wang, Xiaozhen
    Cheng, Na
    Zhang, Jingwen
    Fang, Zhigang
    Long, Bing
    Lin, Dongjun
    CLINICAL LABORATORY, 2018, 64 (7-8) : 1311 - 1315